09 May 2024 Effectiveness of empagliflozin in the treatment of patients with type 2 diabetes mellitus combined with heart failure depending on ATP level (literature review) type 2 diabetes mellitus; heart failure; sodium-glucose co-transporter-2 inhibitors; empagliflozin; adenosine triphosphate Marina Moldobaeva , Uulkan Omurzakova https://doi.org/10.54890/1694-8882-2024-2-53